A Study on the effect of appropriate use of Rasayana Churna Vati and Haritaki Churna in post Covid 19 Pandemic.
- Conditions
- Health Condition 1: J00-J99- Diseases of the respiratory systemHealth Condition 2: J00-J99- Diseases of the respiratory system
- Registration Number
- CTRI/2022/11/046980
- Lead Sponsor
- All India Institute of Ayurveda, Sarita Vihar, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Subjects who have recovered from COVID-19 (RTPCR - negative) having history of mild, moderate, severe infection will be included in the study with persistence of symptoms or development of general sequelae (fatigue, joint pain, muscular pain and fever) beyond 3 or 4â??weeks from the onset of acute symptoms of COVID-19
2.Subjects without any bar of race, religion and gender.
1.Patient less than 21 yrs. and above 60yrs. of age will be excluded.
2.The pregnant women and lactating mother will be excluded.
3.Patients who have completed participation in any other clinical trial during the past six months.
4.Patients with co-morbidities like Chronic Obstructive Pulmonary disease (COPD), Ischemic Heart Disease (IHD), Chronic Kidney Disease (CKD), coagulopathy and cancer.
5.Patients who were on immuno-suppressant, oral steroids or chemotherapy.
6.Patients k/c/o Diabetes Mellitus (DM) taking insulin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant relief in symptoms of post COVID 19 in general sequelae. (Aartasya Rognut effect of Rasyana Churan Vati will be expected )Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Improvement in Quality of LifeTimepoint: 8 weeks